SRTA Stock Analysis: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$5.55
0.53 (10.56%)
▲
5d:
+7.98%
30d:
+2.59%
90d:
+9.25%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $5.55, which is considered extended relative to its 30-day fair value range of $5.04 to $5.34. From a valuation perspective, the stock is trading at a discount (Forward PE: -555.0) compared to its historical average (61.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTA is in a uptrend. The price is approaching resistance at $5.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.6% recently.
Market Sentiment: SRTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.25 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTA is in a uptrend. The price is approaching resistance at $5.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.6% recently.
Market Sentiment: SRTA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.25 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.04 -
$5.34
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.6%)
- BULLISH: Trading 66.7% below Wall St target ($9.25)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$5.04 -
$5.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.86
Resistance Level
$5.58
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-555.00
Wall Street Target
$9.25
(+66.7%)
Revenue Growth (YoY)
87.4%
Profit Margin
20.6%
PE vs Historical
-555.0 vs 61.6
CHEAP
Share & Embed Analysis
Last updated: August 04, 2026 6:53 AM ET
Data refreshes hourly during market hours. Next update: 7:53 AM
Data refreshes hourly during market hours. Next update: 7:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 51 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 52 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 43 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 57 HOLD |